Today's COVID-19 News: December 11, 2020

FDA Statement on Vaccines, Related Biological Products Advisory Committee Meeting

ollowing yesterday’s positive advisory committee meeting outcome regarding the Pfizer-BioNTech COVID-19 vaccine, the U.S. Food and Drug Administration (FDA) has informed the sponsor that it will rapidly work toward finalization and issuance of an Emergency Use Authorization (EUA). Read more... 

Sanofi, GSK Announce Delay in COVIDV19 Vaccine Program

Sanofi and GSK have announced a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in older adults. Read more...

Kantaro Receives EUA for Semi-Quantitative COVID-19 Antibody Test Kit

Kantaro Biosciences, a joint venture between the Mount Sinai Health System and RenalytixAI, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for COVID-SeroKlir, its semi-quantitative SARS-CoV-2 IgG antibody test kit. Read more...